China Approves First Recombinant Botulinum Toxin for Glabellar Lines
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Latest News & Information
Staff's Top Picks
Why Your Website Tracking Could Be a Compliance Liability
The tracking tools many plastic surgery practices rely on for digital advertising may be creating unintended compliance risks. As regulators increase scrutiny, standard website setups could expose patient data in ways that raise both HIPAA and FTC concerns.
Smarter Tools. Better Outcomes. One Weekly Update.
From cutting-edge procedures to patient experience strategies, we deliver the plastic surgery insights that help you save time, improve results, and grow your practice.Plastic Surgery Podcast
Clinic Excellence
Stanford Appoints New Chief of Plastic and Reconstructive Surgery
A Stanford-trained microsurgeon will lead the division starting Sept 1, marking a leadership transition after two decades under the current chief.
Future Focus Trends
Wingderm Receives FDA Clearance for Lasermach Across Three Wavelengths
Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.
Products Shaping Aesthetics
Office Management Solutions
The Aesthetic Society Selects Quest and Crytica to Provide Cybersecurity Services to Members
The partnership gives members access to managed cybersecurity services designed to help protect IT, IoT, and connected medical systems from emerging threats.
